Library

4-AcO-DiPT

4-AcO-DiPT is a synthetic psychedelic of the tryptamine class, first described by Alexander Shulgin by 2003 and encountered as a novel designer drug in 2005. It is thought to act primarily as a prodrug of 4-HO-DiPT. The substance is notable for producing a unique combination of physical euphoria and stimulation alongside atypically minimal visual and introspective psychedelic effects compared to related tryptamines.

Also known as: Ace, Aces, 4-ace, Ipracetin, Iprocetyl

Classification

  • Chemical: Tryptamine
  • Psychoactive: Psychedelic
  • Tag: Hallucinogen
  • Tag: Research-Chemical
  • Tag: substituted tryptamine

Effects

  • Creativity Enhancement
  • Increased Heart Rate
  • Nausea
  • Pupil Dilation
  • Spontaneous Tactile Sensations
  • Mentalphysical Stimulation
  • Analysis Enhancement
  • Conceptual Thinking
  • Delusion
  • Emotion Enhancement
  • Immersion Enhancement
  • Memory Suppression
  • Bodily Control Enhancement
  • Tactile Enhancement
  • Hallucinations
  • Drifting
  • Color Shifting
  • Symmetrical Texture Repetition

Routes of Administration

Oral

Dosage

  • Heavy: 35 mg
  • Light: 5 – 10 mg
  • Common: 10 – 20 mg
  • Strong: 20 – 35 mg
  • Threshold: 3-5 mg

Duration

  • Onset: 0.25-0.67 h
  • Comeup: 0.33-0.67 h
  • Peak: 1.5-2 h
  • Offset: 1-1.5 h
  • After Effects: 2-6 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

4-AcO-DiPT - מדריך חומרים של DrugsPRO

4-AcO-DiPT: 4-AcO-DiPT is a synthetic psychedelic of the tryptamine class, first described by Alexander Shulgin by 2003 and encountered as a novel designer drug in 2005. It is thought to act primarily as a prodrug of 4-HO-DiPT. The substance is notable for producing a unique combination of physical

Related pages